Reserpine treatment of comorbid Tourette's disorder and tardive dystonia.
Rojas
V M
VM
Davies
R K
RK
D018759:Adrenergic Uptake Inhibitors / Q000627:therapeutic use*; D000328:Adult; D015897:Comorbidity; D004409:Dyskinesia, Drug-Induced / Q000188:drug therapy* / Q000453:epidemiology / Q000209:etiology*; D004421:Dystonia / Q000139:chemically induced* / Q000188:drug therapy* / Q000453:epidemiology; D006220:Haloperidol / Q000009:adverse effects* / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D012110:Reserpine / Q000627:therapeutic use*; D005879:Tourette Syndrome / Q000188:drug therapy* / Q000453:epidemiology
D018759:Adrenergic Uptake Inhibitors; D012110:Reserpine; D006220:Haloperidol